Skip to main content

Table 3 Clinical outcomes (Cumulative)

From: N-terminal pro-B-type natriuretic peptide is associated with clinical outcomes after transcatheter aortic valve replacement

 

Responders

(n = 234)

Non-responders

(n = 123)

P value by log-rank test

30-day all-cause mortality

3(1.3)

1(0.8)

0.689

Late all-cause mortality

15(8.6)

18(20.0)

0.009

Late cardiac mortality

7(3.9)

15(16.2)

< 0.001

Rehospitalization for heart failure

12(13.2)

9(8.7)

0.334

All stroke

12(19.5)

6(5.6)

0.943

  1. Values are n (%)